These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18951998)

  • 1. How do we assure the quality of biological medicines?
    Longstaff C; Whitton CM; Stebbings R; Gray E
    Drug Discov Today; 2009 Jan; 14(1-2):50-5. PubMed ID: 18951998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product development of probiotics as biological drugs.
    Sutton A
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S128-32; discussion S144-51. PubMed ID: 18181718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of manufacture--the EC point of view.
    Meyer P
    Dev Biol Stand; 1992; 79():159-62. PubMed ID: 1286750
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilars: opportunity or cause for concern?
    Roger SD; Mikhail A
    J Pharm Pharm Sci; 2007; 10(3):405-10. PubMed ID: 17727803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of manufacture--principles and purposes.
    Luff PR
    Dev Biol Stand; 1992; 79():155-8. PubMed ID: 1286749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems raising from the control of biological products employed in medicine. Control of sera, vaccines, and biological products in France].
    Desbordes J
    Ann Ist Super Sanita; 1969; 5(3-4):218-81. PubMed ID: 16089166
    [No Abstract]   [Full Text] [Related]  

  • 8. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory pathways for vaccines for developing countries.
    Milstien J; Belgharbi L
    Bull World Health Organ; 2004 Feb; 82(2):128-33. PubMed ID: 15042235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO Expert Committee on Biological Standardization.
    Horowitz B; Minor P; Morgenthaler JJ; Burnouf T; McIntosh R; Padilla A; Thorpe R; van Aken WG;
    World Health Organ Tech Rep Ser; 2004; 924():1-232, backcover. PubMed ID: 15693660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of medicinal products derived from human blood or plasma in the European Community.
    Brunko P
    Dev Biol Stand; 1993; 81():269-71. PubMed ID: 8174813
    [No Abstract]   [Full Text] [Related]  

  • 13. The EEC and the regulation of blood derivatives.
    Horaud F
    Dev Biol Stand; 1993; 81():273-6. PubMed ID: 8174814
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO activities to assure the quality of biological products.
    Magrath D
    Dev Biol Stand; 1993; 81():265-8. PubMed ID: 8174812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory for the control of serum vaccines and other biological products].
    M'Henni A
    Arch Inst Pasteur Tunis; 1997; 74(1-2):129-33. PubMed ID: 15945193
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the pharmacopoeia in the control of pharmaceutical preparations.
    Grainger HS
    Ann Ist Super Sanita; 1975; 11(3-4):305-13. PubMed ID: 1234732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registration of veterinary products in Argentina.
    Butler E; Cané BG
    Rev Sci Tech; 1995 Dec; 14(4):1121-31. PubMed ID: 8639950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
    Gay CG
    Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.